Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 13, 2023

BUY
$63.15 - $71.6 $63 - $71
1 Added 0.08%
1,259 $87,000
Q4 2022

Jan 13, 2023

BUY
$54.21 - $70.44 $3,361 - $4,367
62 Added 5.18%
1,258 $0
Q3 2022

Oct 20, 2022

BUY
$53.02 - $135.75 $53 - $135
1 Added 0.08%
1,196 $66,000
Q2 2022

Aug 04, 2022

SELL
$59.26 - $71.14 $12,326 - $14,797
-208 Reduced 14.83%
1,195 $79,000
Q1 2022

Apr 29, 2022

BUY
$55.72 - $67.12 $222 - $268
4 Added 0.29%
1,403 $93,000
Q3 2021

Oct 12, 2021

BUY
$55.56 - $60.79 $111 - $121
2 Added 0.14%
1,399 $84,000
Q2 2021

Jul 15, 2021

SELL
$48.42 - $60.18 $1,694 - $2,106
-35 Reduced 2.44%
1,397 $84,000
Q1 2021

May 03, 2021

BUY
$47.16 - $54.44 $1,886 - $2,177
40 Added 2.87%
1,432 $71,000
Q4 2020

Feb 03, 2021

BUY
$48.52 - $58.02 $9,704 - $11,604
200 Added 16.78%
1,392 $70,000
Q1 2020

May 06, 2020

BUY
$37.79 - $51.33 $75 - $102
2 Added 0.17%
1,192 $53,000
Q4 2019

Jan 21, 2020

BUY
$42.46 - $50.46 $11,124 - $13,220
262 Added 28.23%
1,190 $59,000
Q3 2019

Nov 06, 2019

SELL
$40.12 - $45.47 $13,801 - $15,641
-344 Reduced 27.04%
928 $41,000
Q2 2019

Jul 19, 2019

BUY
$37.28 - $41.68 $47,420 - $53,016
1,272 New
1,272 $52,000
Q2 2018

Aug 15, 2018

SELL
$34.55 - $37.05 $1.01 Million - $1.09 Million
-29,347 Closed
0 $0
Q1 2018

May 07, 2018

BUY
$32.97 - $36.63 $100,855 - $112,051
3,059 Added 11.64%
29,347 $1.03 Million
Q4 2017

Feb 13, 2018

BUY
$32.09 - $34.78 $104,581 - $113,348
3,259 Added 14.15%
26,288 $912,000
Q3 2017

Nov 14, 2017

BUY
$28.96 - $34.0 $622,871 - $731,272
21,508 Added 1414.07%
23,029 $780,000
Q2 2017

Aug 14, 2017

BUY
N/A
1,521
1,521 $52,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $203B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Focused Wealth Management, Inc Portfolio

Follow Focused Wealth Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Focused Wealth Management, Inc with notifications on news.